Bladder Carcinoma

general

A carcinoma arising from the bladder epithelium. Approximately 90% of the bladder carcinomas are transitional cell carcinomas. The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.

85

Centers

160

Active Trials

$622M

Cancer Funding

Specific Cancer Types(3)

Top Centers for Bladder Carcinoma(85)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.8
2
NCI Comprehensive
High-Volume Research Center
71.7
3
High-Volume Research Center
71.7
4
High-Volume Research Center
71.7
5
NCI Comprehensive
Active Research Program
67.1
6
NCI Comprehensive
Active Research Program
67.1
7
NCI Comprehensive
Active Research Program
67.1
8
NCI Comprehensive
Active Research Program
67.1
9
NCI Comprehensive
Active Research Program
67.1
10
NCI Comprehensive
Active Research Program
67.1
11
NCI Comprehensive
Active Research Program
67.1
12
Active Research Program
67.1
13
Active Research Program
67.1
14
NCI Clinical
Active Research Program
67.1
15
Active Research Program
67.1
16
Active Research Program
67.1
17
Active Research Program
67.1
18
Active Research Program
67.1
19
NCI Comprehensive
Active Research Program
46.8
20
NCI Comprehensive
Active Research Program
46.8
21
NCI Comprehensive
Active Research Program
46.8
22
NCI Comprehensive
Active Research Program
46.8
23
NCI Comprehensive
Active Research Program
46.8
24
NCI Comprehensive
Active Research Program
46.8
25
NCI Comprehensive
Active Research Program
46.8
26
NCI Comprehensive
Active Research Program
46.8
27
NCI Comprehensive
Active Research Program
46.8
28
NCI Comprehensive
Active Research Program
46.8
29
NCI Comprehensive
Active Research Program
46.8
30
NCI Comprehensive
Active Research Program
46.8
31
NCI Comprehensive
Active Research Program
46.8
32
NCI Comprehensive
Active Research Program
46.8
33
NCI Comprehensive
Active Research Program
46.8
34
NCI Comprehensive
Active Research Program
46.8
35
NCI Comprehensive
Active Research Program
46.8
36
NCI Comprehensive
Active Research Program
46.8
3746.8
38
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
46.8
39
NCI Comprehensive
Active Research Program
46.8
40
NCI Comprehensive
Active Research Program
46.8
41
NCI Comprehensive
Active Research Program
46.8
42
NCI Comprehensive
Active Research Program
46.8
43
NCI Clinical
Active Research Program
46.8
44
NCI Comprehensive
Active Research Program
46.8
45
NCI Comprehensive
Active Research Program
46.8
46
NCI Comprehensive
Active Research Program
46.8
47
NCI Comprehensive
Active Research Program
46.8
48
NCI Clinical
Active Research Program
46.8
49
Active Research Program
46.8
50
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
46.8
51
Active Research Program
46.8
52
NCI Comprehensive
Active Research Program
46.8
53
NCI Comprehensive
Active Research Program
46.8
54
NCI Clinical
Active Research Program
46.8
55
NCI Comprehensive
Active Research Program
46.8
56
NCI Comprehensive
Active Research Program
46.8
57
NCI Comprehensive
Active Research Program
46.8
58
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
46.8
59
NCI Comprehensive
Active Research Program
46.8
60
Active Research Program
46.8
61
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
46.8
62
NCI Comprehensive
Active Research Program
46.8
6346.8
64
Active Research Program
46.8
65
Active Research Program
46.8
66
NCI Basic_laboratory
Active Research Program
46.8
67
Active Research Program
46.8
68
Active Research Program
46.8
69
Active Research Program
46.8
70
Active Research Program
46.8
71
Active Research Program
46.8
72
Active Research Program
46.8
7346.8
74
Active Research Program
46.8
75
Active Research Program
46.8
76
Active Research Program
46.8
77
Active Research Program
46.8
78
Active Research Program
46.8
7929.2
80
NCI Comprehensive
29.2
81
NCI Clinical
29.2
82
NCI Comprehensive
29.2
83
84
85

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →